Safety of ventricular arrhythmia radiofrequency ablation with half-normal saline irrigation.

Authors:
Hasegawa K; Yoneda ZT; Powers EM; Tokutake K; Kurata M and 11 more

Journal:
Europace

Publication Year: 2024

DOI:
10.1093/europace/euae018

PMCID:
PMC10898929

PMID:
38367008

Journal Information

Full Title: Europace

Abbreviation: Europace

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest: W.G.S.: honoraria from Boston Scientific, Abbott, Johnson and Johnson, Medtronic, and Biotronik and co-holder of a patent for irrigated needle ablation that is consigned to Brigham Hospital. A.N.K.: speaking honoraria from Abbott and Johnson and Johnson. G.F.M.: honoraria/consulting from Boston Scientific, Abbott, Biosense Webster, GE, and Mediasphere. T.D.R.: consultant for Medtronic, Johnson and Johnson, and Philips and research funding from Medtronic and Abbott. The remaining authors have nothing to disclose."

Evidence found in paper:

"Funding K.H.: International Rotary Fellowship of Healthcare Professionals. K.T. and M.K.: scholarship from the Japanese Heart Rhythm Society (grant number: GG2099197). Conflict of interest: W.G.S.: honoraria from Boston Scientific, Abbott, Johnson and Johnson, Medtronic, and Biotronik and co-holder of a patent for irrigated needle ablation that is consigned to Brigham Hospital. A.N.K.: speaking honoraria from Abbott and Johnson and Johnson. G.F.M.: honoraria/consulting from Boston Scientific, Abbott, Biosense Webster, GE, and Mediasphere. T.D.R.: consultant for Medtronic, Johnson and Johnson, and Philips and research funding from Medtronic and Abbott. The remaining authors have nothing to disclose."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025